This article provides an overview of the clinical evidence of interactions between herbal and conventional medicines. Herbs involved in drug interactions – or that have been evaluated in pharmacokinetic trials – are discussed in this review. While many of the interactions reported are of limited clinical significance and many herbal products (echinacea, valerian) seem to expose patients to minor risk under conventional pharmacotherapy, a few herbs, notably St. John’s wort, may provoke adverse events sufficiently serious about endangering the patient’s health. Healthcare professionals should remain vigilant for potential interactions between herbal medicines and prescribed drugs, especially when drugs with a narrow therapeutic index are used. Hypericum perforatum L. (St. John’s wort) extracts are widely used as a safe alternative to conventional antidepressant drugs for mild to moderate forms of depressive disorders. St. John’s wort represents the herbal product that is most involved in herb-to drug interactions. The aim of this article is to provide an overview of the clinical data regarding the E2 interactions between herbal remedies and prescribed drugs. For patients on prescription medications, the concomitant use of herbal medications can cause serious and adverse effects. It is the responsibility of health professionals to be well informed about the clinical evidence of herb-drug interactions.

Background: Induction of labor is a procedure performed to prevent maternal and perinatal morbidity and mortality. The effects of birth control pills on babies are still controversial. Therefore, we conducted this study to compare the effects of oxytocin and misoprostol on fetal blood gas parameters. Aim: To compare the effects of misoprostol and oxytocin used in labor induction on umbilical cord blood parameters Materials and methods: We conducted this study among mothers who gave birth in the NICU, according to the inclusion criteria, a control group (n=30), misoprostol alone vaginally (n=30) and oxytocin drip alone (n= 30) and oxytocin with misoprostol group (n=30) 4 groups used 100 mothers were selected respectively. Umbilical artery blood was sampled and umbilical artery blood pH, pCO2, pO2, HCO3, and VE (blood base excess) parameters were measured in the laboratory. The umbilical cord blood acid-alkaline parameters and lactate levels were analyzed and evaluated using COBAS C311 and COBAS B221 instruments. It was compared and determined using SPSS26 and EXCEL programs. Results: The average age of all mothers included in the study was 27.87±6.12, the average gestation period was 39.6±0.7 weeks, and the average weight of the newborn was 3466±323 gr. The average umbilical cord blood pH value was 7.34±0.04 in the control group, 7.25±0.07 in the oxytocin group, 7.27±0.04 in the misoprostol group, and 7.24±0.04 in the oxytocin and misoprostol group. And lactate valie was 5.8 in the control group, 7.5 in the oxytocin group, 9.87 in the misoprostol group, 8.7 in the combined group. Conclusions Compared to the group that did not use labor-inducing drugs, the mean pH of umbilical cord blood and lactate level were higher or statistically significant in the 3 groups that used labor-inducing drugs, indicating that birth-inducing drugs affect the umbilical cord blood parameters.